Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Advisory Board Co (NASDAQ:ABCO)

39.27
Delayed Data
As of 1:01pm ET
 +0.075 / +0.19%
Today’s Change
38.84
Today|||52-Week Range
60.38
-20.85%
Year-to-Date

Today’s Trading

Previous close39.19
Today’s open39.53
Day’s range39.14 - 40.87
Volume86,313
Average volume (3 months)271,779
Market cap$1.6B
Dividend yield--
Data as of 1:01pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)--
P/E ratio94.6
Price/Sales3.05
Price/Book4.42

Competitors

 Today’s
change
Today’s
% change
NKTRNektar Therapeutics+0.14+1.24%
INCRINC Research Holding...-0.43-1.11%
DBVTDBV Technologies SA-0.42-1.80%
FGENFibroGen Inc+0.46+2.68%
Data as of 1:17pm ET, 02/12/2016

Financials

Next reporting dateFebruary 24, 2016
EPS forecast (this quarter)$0.30
Annual revenue (last year)$581.6M
Annual profit (last year)-$2.3M
Net profit margin-0.39%

Profile

Sector
Health Services
Industry
Services to the Health Industry
Chairman &
Chief Executive Officer
Robert W. Musslewhite
President &
Director
David L. Felsenthal
Corporate headquarters
Washington, District Of Columbia

Forecasts

Partner Offers